Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.7787
+0.0022 (0.28%)
May 13, 2026, 10:11 AM EDT - Market open
Celularity Employees
Celularity had 123 employees as of December 31, 2024. The number of employees increased by 3 or 2.50% compared to the previous year.
Employees
123
Change (1Y)
3
Growth (1Y)
2.50%
Revenue / Employee
$215,854
Profits / Employee
-$745,301
Market Cap
22.46M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 123 | 3 | 2.50% |
| Dec 31, 2023 | 120 | -105 | -46.67% |
| Dec 31, 2022 | 225 | 0 | - |
| Dec 31, 2021 | 225 | 63 | 38.89% |
| Dec 31, 2020 | 162 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 59 |
| Longeveron | 38 |
| Jasper Therapeutics | 22 |
| ABVC BioPharma | 19 |
| Outlook Therapeutics | 17 |
| Lantern Pharma | 16 |
| Barinthus Biotherapeutics | 14 |
| Serina Therapeutics | 13 |
CELU News
- 11 days ago - Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation - GlobeNewsWire
- 16 days ago - NEXGEL Appoints Ian Blackman as Chief Financial Officer - GlobeNewsWire
- 21 days ago - NexGel closes acquisition of products from Celularity - TheFly
- 22 days ago - Celularity announces closing of transaction with NexGel - TheFly
- 22 days ago - Celularity Announces Closing of Transaction with NexGel - GlobeNewsWire
- 25 days ago - Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing - GlobeNewsWire
- 2 months ago - NexGel announces terms of agreement of license for products from Celularity - TheFly
- 2 months ago - Celularity reiterates strategic commercialization partnership with NEXGEL - TheFly